A cost estimate commissioned by the American Diabetes Association, the YMCA of the USA, and the American Medical Association showed that the Medicare Diabetes Prevention Act (H.R. 962), introduced by Rep. Susan Davis (D-San Diego), would reduce federal spending by $1.3 billion.
“This bill is a win-win in that it cuts costs and, more importantly, it would reduce incidents of diabetes in seniors,” said Rep. Davis. “The reality is that preventative care reduces health care costs and is a key to reducing overall health care spending. By expanding targeted prevention initiatives, like the National Diabetes Prevention Program, to seniors on Medicare, we can achieve even greater cost savings by preventing diabetes and its complications.”
The study was conducted by Avalere Health to identify federal savings or costs of H.R. 962 and S. 452 using methods similar to the Congressional Budget Office (CBO). S. 452 is the Senate companion legislation.
The Medicare Diabetes Prevention Act would extend the proven benefits of the National Diabetes Prevention Program (DPP) to seniors under Medicare. Established as a result of Davis’s Diabetes Prevention Act, the DPP provides grants to health and community organizations to help those with pre-diabetes prevent full onset of Type II.